Form D · Biotechnology
BirchBioMed Inc.
King City, A6 · CIK 0001670747
Offering snapshot reported Oct 1, 2025 · SEC filing
- Reported sold
- $2.48M Offering amount: $5M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 27, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$175,000 → $2,480,000
- Reported investors5 → 18
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 1, 2025 | Amendment | $2,480,000 | $2,305,000vs Jul 11, 2025 | 18 | SEC filing |
| Jul 11, 2025 | Initial | $175,000 | No comparison | 5 | SEC filing |
| Nov 1, 2021 | Initial | $596,013 | No comparison | 5 | SEC filing |
| Aug 28, 2020 | Initial | $398,715 | No comparison | 10 | SEC filing |
| Feb 5, 2020 | Amendment | $5,302,550 | $1,332,000vs Feb 25, 2019 | 97 | SEC filing |
| Feb 25, 2019 | Amendment | $3,970,550 | $2,565,531vs Sep 20, 2017 | 65 | SEC filing |
| Sep 20, 2017 | Amendment | $1,405,019 | No comparison | 20 | SEC filing |
| Mar 30, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-551459
Source: Form D, filed Oct 1, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Teresa Bair | Director |
| Carlos Camozzi | Executive |
| Susan Elliott | Director, Executive, Promoter |
| Charles Ellis | Director |
| Herve Girsault | Executive |
| Ryan V. Hartwell | Director, Executive, Promoter |
| Mark Miller | Director, Executive, Promoter |
| Joseph Sardano | Director |
| Richard J. Shaw | Executive |
| John Verbeck | Executive |
| Jon Verbeck | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
130 Kingscross Drive
King City, A6, L7B 1E6
King City, A6, L7B 1E6